OPKO Health, Inc. (OPK)

NMS – Real vaqt narxi. Valyuta: USD

1.38

-0.01 (-0.72%)

Bozor ochiq: Aug 12, 2026, 11:26 AM EDT

1.37

-0.02 (-1.44%)

Oldingi bozordan keyin: Aug 11, 2026, 7:42 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

04.08.2026

OPKO Health: Mazdutide And MDX-2201 Could Change Everything

On July 27, OPKO Health, Inc. released its Q2 numbers. So, OPK's revenue from transfer of IP and other increased 208% YoY to $46.1 million in Q2, driven by a Nicoya license amendment. Also, OPKO raised its full-year 2026 revenue guidance from $530-$560 million to $560-$585 million.

04.08.2026

OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

OPKO Health (OPK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Videolar

No Data

There is no data to display

OPKO Health, Inc. (OPK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

OPKO Health, Inc. (OPK)

OPKO Health: Mazdutide And MDX-2201 Could Change Everything

OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

Videolar

No Data

OPKO Health: Mazdutide And MDX-2201 Could Change Everything

OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

Videolar

No Data

Search stocks

OPKO Health, Inc. (OPK)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

OPKO Health, Inc. (OPK)

OPKO Health: Mazdutide And MDX-2201 Could Change Everything

OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

Videolar

No Data

OPKO Health: Mazdutide And MDX-2201 Could Change Everything

OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

Videolar

No Data